NEW YORK (Reuters Health) – Simple tests performed during an office visit can help identify who can safely drive after a stroke, investigators from Belgium and the US…
NEW YORK (Reuters Health) – Patients with type 2 diabetes have better glycemic control and less nausea when exenatide is given weekly rather than twice daily, according to…
NEW YORK (Reuters Health) – Warming local anesthetics to body temperature significantly reduces pain from the injection, according to the results of a meta-analysis conducted by Canadian investigators…
NEW YORK (Reuters Health) – A new study provides more evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome (ACS). In the…
NEW YORK (Reuters health) – The effects of cardiac resynchronization may be more dramatic in patients with advanced heart failure, but those with less severe symptoms also benefit…
NEW YORK (Reuters Health) – For initial treatment of HIV-1 infection, once daily atazanavir plus ritonavir and once-daily efavirenz provide comparable antiviral efficacy when used with either abacavir/lamivudine…
NEW YORK (Reuters Health) – Oral contraceptives are just as effective as a gonadotropin-releasing hormone (GnRH) agonist for relieving pelvic pain due to endometriosis, results of a small…
NEW YORK (Reuters Health) – For women with thyroid cancer treated with radioiodine-131, subsequent pregnancy is safe without adverse outcomes for the offspring. That’s according to a report…
NEW YORK (Reuters Health) – In older adults, mean serum levels of 25-hydroxyvitamin D are somewhat higher after a year of taking cholecalciferol (vitamin D3) compared to ergocalciferol…
NEW YORK (Reuters Health) – Research shows that biliopancreatic diversion (BPD) significantly reduces renal and cardiovascular complications over 10 years in morbidly obese individuals with newly diagnosed type…